Every DEF 14A that Tenon Medical, Inc. (TNON) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow TNON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TNON filings page.
Tenon Medical, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on July 23, 2026. The proxy covers election of seven directors, ratification of Haskell & White LLP as auditor, and a reverse stock split at a ratio between 1-for-2 and 1-for-35.
Stockholders are also asked to approve Nasdaq Listing Rule 5635(d)-related items, including shares issuable under March 11, 2026 debt financing and potential future financings below the “Minimum Price,” plus authority to adjourn the meeting if needed. Common and preferred holders vote together, with Series A and B preferred carrying 1.25 votes per share.
Tenon Medical, Inc. has rescheduled its previously adjourned Annual Meeting to be held virtually on September 18, 2025, at 10:30 a.m. Pacific Time. The meeting had been adjourned on July 23, 2025 and August 20, 2025.
Only shareholders of record at the close of business on August 22, 2025 are entitled to notice and to vote. Stockholders must use a Virtual Control Number to participate and vote electronically, with additional steps required for those holding shares in “street name.” The company urges shareholders to vote before September 16, 2025 to ensure their votes are received and counted.